Correlation Between Verve Therapeutics and Bio Techne
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Bio Techne Corp, you can compare the effects of market volatilities on Verve Therapeutics and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Bio Techne.
Diversification Opportunities for Verve Therapeutics and Bio Techne
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Verve and Bio is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Bio Techne Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne Corp and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne Corp has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Bio Techne go up and down completely randomly.
Pair Corralation between Verve Therapeutics and Bio Techne
Given the investment horizon of 90 days Verve Therapeutics is expected to generate 2.78 times more return on investment than Bio Techne. However, Verve Therapeutics is 2.78 times more volatile than Bio Techne Corp. It trades about 0.05 of its potential returns per unit of risk. Bio Techne Corp is currently generating about -0.17 per unit of risk. If you would invest 601.00 in Verve Therapeutics on December 2, 2024 and sell it today you would earn a total of 32.00 from holding Verve Therapeutics or generate 5.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Verve Therapeutics vs. Bio Techne Corp
Performance |
Timeline |
Verve Therapeutics |
Bio Techne Corp |
Verve Therapeutics and Bio Techne Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verve Therapeutics and Bio Techne
The main advantage of trading using opposite Verve Therapeutics and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Bio Techne vs. Biomarin Pharmaceutical | Bio Techne vs. Vaxcyte | Bio Techne vs. Liquidia Technologies | Bio Techne vs. Legend Biotech Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies |